| Quarterly Financials | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
Revenue  | 132 | 151 | 156 | 172 | 164 | 174 | 215 | 220 | 203 | 216 | 235 | 208 | 259 | 340 | 310 | 291 | 388 | 398 | 399 | 372 | 303 | 404 | 350 | 367 | 404 | 425 | 449 | 427 | 459 | 443 | 458 | 471 | 430 | 442 |
| Expenses | 121 | 130 | 137 | 154 | 152 | 157 | 195 | 197 | 184 | 198 | 215 | 188 | 231 | 305 | 278 | 256 | 343 | 353 | 364 | 350 | 288 | 374 | 328 | 348 | 375 | 388 | 394 | 375 | 404 | 394 | 417 | 424 | 401 | 381 |
| EBITDA | 11 | 20 | 19 | 18 | 12 | 17 | 19 | 23 | 20 | 18 | 20 | 21 | 28 | 36 | 33 | 35 | 45 | 45 | 35 | 22 | 16 | 30 | 22 | 19 | 29 | 37 | 55 | 53 | 55 | 49 | 42 | 47 | 29 | 61 |
| Operating Profit % | 7 % | 13 % | 12 % | 10 % | 7 % | 10 % | 8 % | 10 % | 10 % | 7 % | 7 % | 9 % | 10 % | 9 % | 10 % | 11 % | 11 % | 11 % | 8 % | 5 % | 5 % | 7 % | 6 % | 4 % | 7 % | 8 % | 11 % | 11 % | 11 % | 10 % | 8 % | 9 % | 6 % | 7 % |
| Depreciation | 9 | 8 | 8 | 10 | 9 | 10 | 10 | 11 | 12 | 8 | 9 | 9 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 8 | 8 | 8 | 10 | 6 | 2 | 5 | 17 | 9 | 11 |
| Interest | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | -0 | 0 | -9 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 2 | 1 | 1 | 1 | 1 | 5 | 4 | 4 |
| Profit Before Tax | 1 | 11 | 10 | 7 | 3 | 7 | 9 | 11 | 8 | 9 | 11 | 11 | 20 | 28 | 24 | 28 | 39 | 47 | 27 | 14 | 8 | 22 | 14 | 11 | 21 | 29 | 44 | 42 | 48 | 46 | 35 | 26 | 16 | 46 |
| Tax | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 1 | 8 | 10 | 6 | 2 | 3 | 7 | 5 | 3 | 6 | 7 | 12 | 14 | 12 | 11 | 9 | 5 | 4 | 5 |
| Net Profit | 1 | 11 | 10 | 7 | 3 | 7 | 9 | 11 | 8 | 4 | 11 | 11 | 19 | 27 | 24 | 27 | 31 | 37 | 22 | 12 | 6 | 16 | 9 | 8 | 15 | 21 | 32 | 29 | 36 | 35 | 27 | 20 | 11 | 41 |
| EPS in ₹ | 0.03 | 0.25 | 0.23 | 0.15 | 0.05 | 0.16 | 0.20 | 0.23 | 0.17 | 0.09 | 0.24 | 0.25 | 0.43 | 0.60 | 0.53 | 0.59 | 0.68 | 0.83 | 0.48 | 0.27 | 0.12 | 0.33 | 0.15 | 0.16 | 0.29 | 0.42 | 0.63 | 0.54 | 0.71 | 0.65 | 0.49 | 0.35 | 0.20 | 0.75 |
Morepen Laboratories
Morepen Laboratories
46.28
+0.01
(0.02%)
Q1 Quarterly Results are out. Check out the updated financials1 day ago
View
Key Fundamentals
Market Cap
2,535.40 Cr
EPS
2.20
PE Ratio
27.35
Dividend Yield
0.43 %
Industry
Healthcare 52 Week High
91.70
52 Week Low
42.00
PB Ratio
2.20
Debt to Equity
0.07
Sector
Pharmaceuticals Actual
Company News
View All News
Morepen Laboratories Plans ₹350 Cr Investment in USFDA-Compliant Facilities3 days ago
Morepen Laboratories announced expansion plans in chronic therapies and API exports, investing ₹350 crore in new USFDA-compliant facilities at Baddi and Parwanoo while strengthening its position in cardiovascular and antidiabetic APIs. The company is targeting double-digit revenue CAGR with 20% margin profile by FY28 and foraying into peptide-based drug ingredients and nutraceuticals for export markets.
Morepen Laboratories Reports No Deviation in Rs 200 Crore QIP Fund Utilization3 days ago
Care Ratings Limited submitted its quarterly monitoring report for Morepen Laboratories' Rs 200 crore QIP proceeds for the quarter ended September 30, 2025, confirming no deviation from stated objectives. The funds are being utilized for manufacturing facility modernization at Baddi and Masukhana plants and working capital requirements, with timeline extensions approved by the QIP committee due to ongoing civil and infrastructure work.
Morepen Laboratories Reports Strong Quarterly Results with Exceptional Gains from Subsidiary Divestment3 days ago
Morepen Laboratories posted consolidated net profit of Rs. 4,087.46 lakhs for the quarter ended September 30, 2025, boosted by exceptional gains of Rs. 2,582.54 lakhs from selling its stake in Dr. Morepen Limited and loss of control accounting. The company's shareholding in Dr. Morepen Limited reduced from 80% to 19.96% on July 31, 2025, resulting in it ceasing to be a subsidiary, while the Board approved a final dividend of Rs. 0.20 per equity share paid in September 2025.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,763.90 | #1 4,21,587.10 | 40.19 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 72.45 | |
6,518.50 | 1,72,859.90 | 69.56 | 9,712.00 | 18.67 | 2,191 | 35.10 | 50.21 | |
3,819.40 | 1,29,685.50 | 60.73 | 11,539.40 | 6.99 | 1,911 | 30.46 | 68.95 | |
1,535.60 | 1,23,756.00 | 22.77 | 28,409.50 | 7.12 | 5,291 | 3.71 | 49.08 | |
1,244.40 | 1,03,992.90 | #1 18.11 | 33,741.20 | 16.73 | 5,725 | -0.38 | 52.18 | |
934.75 | 95,033.80 | 18.89 | 23,511.00 | 18.55 | 4,615 | 34.60 | 34.63 | |
2,052.10 | 93,876.80 | 21.59 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 64.79 | |
2,247.00 | 93,576.50 | 52.74 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 31.45 | |
1,236.90 | 71,003.00 | 20.93 | 32,345.60 | 9.43 | 3,484 | 3.81 | 75.20 | |
5,723.00 | 68,421.10 | 28.40 | 13,458.30 | 3.70 | 2,216 | 10.98 | 64.57 |
Growth Rate
Revenue Growth
7.36 %
Net Income Growth
22.15 %
Cash Flow Change
-56.30 %
ROE
-12.81 %
ROCE
-18.00 %
EBITDA Margin (Avg.)
3.85 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 489 | 524 | 538 | 586 | 615 | 664 | 858 | 1,070 | 1,111 | 1,293 | 1,778 |
| Fixed Assets | 323 | 297 | 272 | 264 | 236 | 216 | 225 | 252 | 267 | 307 | 489 |
| Current Assets | 115 | 157 | 192 | 243 | 300 | 372 | 527 | 734 | 756 | 889 | 1,159 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 14 | 17 | 25 | 28 |
| Investments | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 85 |
| Other Assets | 167 | 227 | 267 | 321 | 379 | 446 | 631 | 804 | 827 | 960 | 1,176 |
| Total Liabilities | 489 | 524 | 538 | 586 | 615 | 664 | 858 | 1,070 | 1,111 | 1,293 | 1,778 |
| Current Liabilities | 128 | 167 | 325 | 340 | 339 | 351 | 404 | 457 | 321 | 402 | 501 |
| Non Current Liabilities | 74 | 58 | 18 | 20 | 23 | 28 | 30 | 36 | 37 | 44 | 91 |
| Total Equity | 287 | 300 | 196 | 226 | 253 | 284 | 424 | 578 | 752 | 847 | 1,187 |
| Reserve & Surplus | 78 | 91 | 106 | 136 | 163 | 194 | 291 | 457 | 651 | 745 | 1,047 |
| Share Capital | 210 | 210 | 90 | 90 | 90 | 90 | 90 | 96 | 102 | 102 | 110 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -0 | -5 | 3 | -1 | 4 | 4 | 28 | -26 | 6 | -5 | 10 |
| Investing Activities | -32 | -27 | -14 | -27 | -13 | -13 | -70 | -32 | -47 | -83 | -322 |
| Operating Activities | 51 | 50 | 41 | 63 | 17 | 11 | 51 | -60 | -91 | 73 | 32 |
| Financing Activities | -19 | -27 | -24 | -38 | -0 | 6 | 47 | 66 | 144 | 5 | 300 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | May 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Aug 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 34.54 % | 34.54 % | 34.54 % | 34.54 % | 38.38 % | 36.74 % | 36.74 % | 38.22 % | 38.22 % | 38.22 % | 38.22 % | 38.22 % | 38.22 % | 38.22 % | 38.22 % | 35.65 % | 35.65 % | 35.65 % | 35.65 % | 35.65 % | 35.65 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 1.29 % | 0.00 % | 1.85 % | 1.67 % | 7.72 % | 2.08 % | 2.22 % | 1.94 % | 1.72 % | 1.62 % |
| DIIs | 2.89 % | 2.03 % | 1.26 % | 1.16 % | 1.07 % | 4.07 % | 4.07 % | 3.60 % | 3.74 % | 2.93 % | 2.33 % | 2.28 % | 2.00 % | 2.15 % | 2.15 % | 2.90 % | 1.70 % | 1.64 % | 1.67 % | 1.51 % | 1.50 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % |
| Public / Retail | 42.97 % | 43.89 % | 44.82 % | 45.18 % | 42.50 % | 40.88 % | 40.91 % | 43.63 % | 44.03 % | 45.04 % | 45.49 % | 45.56 % | 44.44 % | 45.03 % | 45.22 % | 41.89 % | 48.16 % | 48.35 % | 48.76 % | 49.35 % | 49.96 % |
| Others | 19.60 % | 19.54 % | 19.38 % | 19.12 % | 18.05 % | 18.31 % | 18.29 % | 14.53 % | 13.99 % | 13.80 % | 13.95 % | 12.64 % | 15.33 % | 12.74 % | 12.74 % | 11.83 % | 12.41 % | 12.12 % | 11.96 % | 11.76 % | 11.26 % |
| No of Share Holders | 1,65,609 | 2,30,611 | 2,44,924 | 2,55,155 | 2,60,933 | 2,83,547 | 2,87,115 | 2,87,370 | 3,06,030 | 3,06,150 | 3,01,832 | 3,04,001 | 3,04,289 | 3,36,019 | 3,48,766 | 3,52,839 | 4,30,929 | 4,48,361 | 4,68,860 | 4,61,180 | 4,61,853 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.2 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.43 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 02 Feb 2023 |  Change Of Name | NA | 02 Feb 2023 | 28.05 | 28.05 |
| 18 Mar 2024 |  Extraordinary General Meeting | NA | 18 Mar 2024 | 53.30 | 41.96 |
| 28 Sept 2024 |  Annual General Meeting | NA | 28 Sept 2024 | 96.19 | 86.63 |
| 11 Nov 2024 |  Quarterly Result Announcement | NA | 11 Nov 2024 | 82.35 | 83.34 |
| 06 Feb 2025 | Quarterly Result Announcement | NA | 06 Feb 2025 | 64.67 | 66.62 |
| 10 Feb 2025 | Extraordinary General Meeting | NA | 10 Feb 2025 | 68.14 | 61.26 |
| 12 May 2025 | Quarterly Result Announcement | NA | 12 May 2025 | 59.26 | 56.23 |
| 06 Aug 2025 | Quarterly Result Announcement | NA | 06 Aug 2025 | 58.45 | 56.56 |
| 30 Aug 2025 |  Dividend | ₹ 0.20 /share | 29 Aug 2025 | 56.23 | 46.67 |
| 06 Sept 2025 | Annual General Meeting | NA | 06 Sept 2025 | 56.56 | 49.31 |
| 14 Nov 2025 | Quarterly Result Announcement | NA | 14 Nov 2025 | 47.44 | 46.59 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication
2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Monitoring Agency Report3 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Investor Presentation3 days ago
3 days agoQ2 FY26 Financial Results3 days ago
3 days agoBoard Meeting Outcome for Board Meeting Outcome Q2 FY26 Financial Results3 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements7 days ago
7 days agoBoard Meeting Intimation for Q-2 FY26 Results10 days ago
10 days agoReport On Transfer Requests Of Physical Shares Re-Lodged Under The Special WindowNov 06, 2025
Nov 06, 2025Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special WindowOct 13, 2025
Oct 13, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 06, 2025
Oct 06, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special WindowSep 23, 2025
Sep 23, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 20, 2025
Sep 20, 2025Execution Of Joint Venture AgreementSep 08, 2025
Sep 08, 2025Formation Of To Be Incorporated Joint Venture CompanySep 08, 2025
Sep 08, 2025Announcement under Regulation 30 (LODR)-AcquisitionSep 08, 2025
Sep 08, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 06, 2025
Sep 06, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 06, 2025
Sep 06, 2025Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special WindowAug 29, 2025
Aug 29, 2025Announcement under Regulation 30 (LODR)-Credit RatingAug 22, 2025
Aug 22, 2025Intimation Of Incorporation Of A Step Down Subsidiary CompanyAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 13, 2025
Aug 13, 2025Letter To Members (No E-Mail Id Registered) Comprising Weblink Of The Annual Report : 2024-25Aug 12, 2025
Aug 12, 2025Business Responsibility and Sustainability Reporting (BRSR)Aug 12, 2025
Aug 12, 2025Notice Of 40Th AGMAug 12, 2025
Aug 12, 2025Reg. 34 (1) Annual Report.Aug 12, 2025
Aug 12, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 06, 2025
Aug 06, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 06, 2025
Aug 06, 2025Approval Of Notice Of AGM Scheduled To Be Held On Saturday September 06 2025Aug 06, 2025
Aug 06, 2025Intimation For Fixation Of Record Date For Payment Of Final Dividend I.E. August 30 2025Aug 06, 2025
Aug 06, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 06, 2025
Aug 06, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 06, 2025
Aug 06, 2025Q1-FY 26 Unaudited Financial ResultsAug 06, 2025
Aug 06, 2025Board Meeting Outcome for For Q1 FY26 Results And OthersAug 06, 2025
Aug 06, 2025Board Meeting Intimation for Q-1 FY26 ResultsAug 01, 2025
Aug 01, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015Jul 31, 2025
Jul 31, 2025Intimation Of Formation Of A Step Down Subsidiary CompanyJul 25, 2025
Jul 25, 2025Incorporation Of A Step-Down Subsidiary Company In Mainland Dubai United Arab Emirates.Jul 22, 2025
Jul 22, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015Jun 30, 2025
Jun 30, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJun 21, 2025
Jun 21, 2025Incorporation Of A Wholly Owned Subsidiary In Dubai United Arab Emirates.Jun 18, 2025
Jun 18, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJun 04, 2025
Jun 04, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2025
May 28, 2025Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsMay 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 17, 2025
May 17, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 13, 2025
May 13, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 13, 2025
May 13, 2025Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)May 13, 2025
May 13, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.12% | 24 | -0.01% | 0.00% |
Technical Indicators
RSI(14)
Neutral 35.96
ATR(14)
Volatile 1.24
STOCH(9,6)
Neutral 20.01
STOCH RSI(14)
Neutral 34.05
MACD(12,26)
Bearish -0.09
ADX(14)
Weak Trend 14.26
UO(9)
Bearish 32.83
ROC(12)
Downtrend And Accelerating -4.30
WillR(14)
Oversold -82.61
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
